Post-Marketing Safety Studies Could Be Funded By User Fees, Cmte. Suggests
Executive Summary
User fees to fund post-marketing safety assessments should be considered in negotiations for the reauthorization of the Prescription Drug User Fee Act, a former FDA official and member of the Drug Safety & Risk Management Advisory Committee suggested